Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Summary of track A: basic science

D L Birx1, T VanCott, N Michael

  • 1Division of Retrovirology, Walter Reed Army Institute of Research, Rockville, Maryland, USA.

AIDS (London, England)
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the Blood Microbiome in Parkinson's Disease, Schizophrenia, and Posttraumatic Stress Disorder.

Brain and behavior·2025
Same author

Association between the relative abundance of butyrate-producing and mucin-degrading taxa and Parkinson's disease.

Neuroscience·2025
Same author

Innovative interdisciplinary emergency neurology rotation: Building bridges for enhanced patient care.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Genetic screening of South African families with Parkinson's disease.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Self-Reported Early and Later Life Weight and the Risk of All-Cause Mortality in Older Adults.

The journal of nutrition, health & aging·2023
Same author

Correlates of Meal Skipping in Community Dwelling Older Adults: A Cross-Sectional Study.

The journal of nutrition, health & aging·2023
Same journal

Hazardous alcohol use, sexual behavior, and recent and undiagnosed HIV across 11 Eastern and Southern African countries.

AIDS (London, England)·2026
Same journal

Carotid inflammation on FDG-PET is associated with lower cognitive performance in people with treated HIV infection.

AIDS (London, England)·2026
Same journal

Clinical implications of the new definition of obesity among persons with HIV.

AIDS (London, England)·2026
Same journal

Cabotegravir and rilpivirine resistance-associated mutations among people with newly diagnosed HIV-1 in the Netherlands.

AIDS (London, England)·2026
Same journal

Pitavastatin effect on enterocyte injury markers in an ART treated HIV population: Insights from REPRIEVE.

AIDS (London, England)·2026
Same journal

Blood pressure control in people with HIV and established atherosclerotic cardiovascular disease: a real-world descriptive analysis.

AIDS (London, England)·2026
See all related articles

Advancements in virologic tools and understanding of HIV-1 pathogenesis are driving new treatment and vaccine strategies. Global collaboration is essential for controlling the international spread of HIV-1 and developing effective vaccines.

Area of Science:

  • Virology
  • Immunology
  • Genetics
  • Epidemiology

Background:

  • Human Immunodeficiency Virus (HIV) continues to be a global health challenge.
  • Understanding HIV-1 pathogenesis and spread is crucial for developing effective interventions.

Purpose of the Study:

  • To review advancements in HIV research, focusing on Track A's five key areas.
  • To highlight progress in virologic tools, pathogenesis understanding, treatment strategies, vaccine development, and genotype analysis.

Main Methods:

  • Utilizing new virologic tools for evaluating therapies, vaccine candidates, and viral spread.
  • Analyzing recent insights into HIV-1 pathogenesis for novel treatment approaches.
  • Reviewing drug and immunologic/genetic advances in HIV treatment.

Related Experiment Videos

  • Examining research on vaccine-induced protective immune responses.
  • Investigating HIV genotypes, recombination, and international strain diversity.

    • Main Results:

    • New virologic tools enhance evaluation of HIV therapies, vaccines, and spread.
    • Understanding pathogenesis informs strategies like early aggressive treatment and blocking viral entry.
    • Advances in HIV treatment include combination therapies, new compounds (integrase, tat/rev inhibitors), and biologics.
    • Vaccine research focuses on protective immune responses, including CD8 suppression and correlates of protection.
    • HIV-1 genotypes show international intermixing and recombination, increasing diversity and fitness.

    Conclusions:

    • HIV-1 spread is global and transcends borders.
    • Effective HIV control requires universally effective vaccines and international collaboration.
    • Basic scientists must engage with international epidemic science for future success.